1595282-86-2

Upstream product

• 626-01-7 3-Iodoaniline 

Downstream Products

• 1313803-05-2 N-(4-methyl-5-(N-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenyl)sulfamoyl)thiazol-2-yl)acetamide 
• 1313803-06-3 C₂₈H₂₁F₃N₂O₄S₂ 
• 1313803-02-9 5-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)m-cresotic acid 
• 1313803-08-5 4-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)nitrobenzene 
• 1313803-07-4 3-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)nitrobenzene 
• 1313802-97-9 2-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)nitrobenzene 
• 1313802-91-3 4-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)benzoic acid 
• 1313802-93-5 3-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)benzoic acid 
• 1313802-92-4 2-(3-(4-(4-(trifluoromethyl)phenyl)-1H-indol-1-yl)phenylaminosulfonyl)benzoic acid 

Relevant academic research and scientific papers

Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors

Methylation of histones by lysine methyltransferases (KMTases) plays important roles in regulating chromatin function. It is also now clear that improper KMTases activity is linked to human diseases, such as cancer. We report an approach that employs drug